Skip to main content
SpringerLink
Log in

Adipocytokines during pregnancy and postpartum in women with gestational diabetes and healthy controls

  • Original Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Background: This study aims to explore the changes in maternal serum adipocytokines during pregnancy and post partum in normal and complicated with gestational diabetes (GDM) pregnancies and to investigate the relationship between serum adipocytokines and some of major metabolic parameters. Materials and methods: 236 pregnant women (127 with GDM and 109 control group) and 50 postpartum women (30 with GDM during pregnancy and 20 controls). Using ELISA and EIA kits, serum levels of adipocytokines were tested during pregnancy and post partum. Maternal adipocytokines levels were correlated with some metabolic parameters. Results: Women with GDM had lower values of adiponectin and higher values of leptin during pregnancy (p<0.001; 0.0001) and post partum (p<0.002; 0.0001). Serum apelin was significantly lower in GDM group (p<0.009). However, we did not find significance for resistin (p<0.317) and apelin (p<0.218). Positive correlation for leptin and negative for adiponectin was found for pre-pregnancy and pregnancy body mass index, glycated hemoglobin and homeostasis model assessment of insulin resistance index. Using cut point of 8.2 µg/ml for adiponectin and 28.7 ng/ml for leptin could exclude GDM with a sensitivity of 83.6%/81.2% and specificity of 56.6%/64.2% (area under the curve 0.702 and 0.827). Conclusion: There are constant differences in adiponectin and leptin levels between GDM and control group during pregnancy and post partum. Apelin was decreased in our GDM group and no differences were found for resistin and visfatin. Further studies are required to verify the mechanism of this alteration and whether the adipocytokines can be predictors for GDM at an early stage of pregnancy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Sun WJ, Yang HX. Maternal and fetal outcomes in pregnant women with abnormal glucose metabolism. Zhonghua Fu Chan Ke Za Zhi 2007, 42: 377–81.

    PubMed  Google Scholar 

  2. Metzger BE, Buchanan TA, Coustan DR, et al. Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 2007, 30(Suppl 2): S251–60.

    Article  PubMed  Google Scholar 

  3. Miehle K, Stepan H, Fasshauer M. Leptin, adiponectin and other adipokines in gestational diabetes mellitus and pre-eclampsia. Clin Endocrinol (Oxf) 2012, 76: 2–11.

    Article  Google Scholar 

  4. Valsamakis G, Kumar S, Creatsas G, Mastorakos G. The effects of adipose tissue and adipocytokines in human pregnancy. Ann NY Acad Sci 2010, 1205: 76–81.

    Article  PubMed  Google Scholar 

  5. Vitoratos N, Deliveliotou A, Vlahos NF, et al. Serum adiponectin during pregnancy and postpartum in women with gestational diabetes and normal controls. Gynecol Endocrinol 2008, 24: 614–9.

    Article  PubMed  Google Scholar 

  6. Briana DD, Malamitsi-Puchner A. Reviews: adipocytokines in normal and complicated pregnancies. Reprod Sci 2009, 16: 921–37.

    Article  PubMed  Google Scholar 

  7. Lacquemant C, Vasseur F, Lepretre F, Froguel P. Adipocytokines, obesity and development of type 2 diabetes. Med Sci (Paris) 2003, 19: 809–17.

    Article  Google Scholar 

  8. Wiecek A, Adamczak M, Chudek J. Adiponectin — an adipokine with unique metabolic properties. Nephrol Dial Transplant 2007, 22: 981–8.

    Article  PubMed  Google Scholar 

  9. Horosz E, Bomba-Opon DA, Szymanska M, Wielgos M. Third trimester plasma adiponectin and leptin in gestational diabetes and normal pregnancies. Diabetes Res Clin Pract 2011, 93: 350–6.

    Article  PubMed  Google Scholar 

  10. Worda C, Leipold H, Gruber C, Kautzky-Willer A, Knofler M, Bancher-Todesca D. Decreased plasma adiponectin concentrations in women with gestational diabetes mellitus. Am J Obstet Gynecol 2004, 191: 2120–4.

    Article  PubMed  Google Scholar 

  11. Liu T, Liu Q, Yang D, Fang Z. Relationship of serum levels of adiponectin, leptin, tumor necrosis factor-alpha and c-reactive protein with insulin resistance during first trimester pregnancy. Zhonghua Yi Xue Za Zhi 2011, 91: 1058–60.

    PubMed  Google Scholar 

  12. Trayhurn P, Beattie JH. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc 2001, 60: 329–39.

    Article  PubMed  Google Scholar 

  13. Sattar N, Greer IA, Pirwani I, Gibson J, Wallace AM. Leptin levels in pregnancy: marker for fat accumulation and mobilization? Acta Obstet Gynecol Scand 1998, 77: 278–83.

    Article  PubMed  Google Scholar 

  14. Wang Q, Guo T, Tao Y, Song Y, Huang W. Association between serum adipocyte factor level and insulin resistance in polycystic ovarian syndrome. Gynecol Endocrinol 2011, 27: 931–4.

    Article  PubMed  Google Scholar 

  15. Wauters M, Considine RV, Van Gaal LF. Human leptin: from an adipocyte hormone to an endocrine mediator. Eur J Endocrinol 2000, 143: 293–311.

    Article  PubMed  Google Scholar 

  16. Steppan CM, Lazar MA. The current biology of resistin. J Intern Med 2004, 255: 439–47.

    Article  PubMed  Google Scholar 

  17. Vitoratos N, Deliveliotou A, Dimitrakaki A, et al. Maternal serum resistin concentrations in gestational diabetes mellitus and normal pregnancies. J Obstet Gynaecol Res 2011, 37: 112–8.

    Article  PubMed  Google Scholar 

  18. Kourtis A, Gkiomisi A, Mouzaki M, et al. Apelin levels in normal pregnancy. Clin Endocrinol 2011, 75: 367–71.

    Article  Google Scholar 

  19. Fukuhara A, Matsuda M, Nishizawa M, et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005, 307: 426–30.

    Article  PubMed  Google Scholar 

  20. Szamatowicz J, Kuzmicki M, Telejko B, et al. Serum visfatin concentration is elevated in pregnant women irrespectively of the presence of gestational diabetes. Ginekol Pol 2009, 80: 14–8.

    PubMed  Google Scholar 

  21. Metzger BE, Gabbe SG, Persson B, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010, 33: 676–82.

    Article  PubMed  Google Scholar 

  22. Report of WHO/IDF consultation. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia, 2006.

  23. Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001, 86: 1930–5.

    Article  PubMed  Google Scholar 

  24. Schondorf T, Maiworm A, Emmison N, Forst T, Pfutzner A. Biological background and role of adiponectin as marker for insulin resistance and cardiovascular risk. Clin Lab 2005, 51: 489–94.

    PubMed  Google Scholar 

  25. Saucedo R, Zarate A, Basurto L, et al. Relationship between circulating adipokines and insulin resistance during pregnancy and postpartum in women with gestational diabetes. Arch Med Res 2011, 42: 318–23.

    Article  PubMed  Google Scholar 

  26. Cortelazzi D, Corbetta S, Ronzoni S, et al. Maternal and foetal resistin and adiponectin concentrations in normal and complicated pregnancies. Clin Endocrinol 2007, 66: 447–53.

    Article  Google Scholar 

  27. Gao XL, Yang HX, Zhao Y. Variations of tumor necrosis factor-alpha, leptin and adiponectin in mid-trimester of gestational diabetes mellitus. Chin Med J 2008, 121: 701–5.

    PubMed  Google Scholar 

  28. McLachlan KA, O’Neal D, Jenkins A, Alford FP. Do adiponectin, TNF-alpha, leptin and CRP relate to insulin resistance in pregnancy? Studies in women with and without gestational diabetes, during and after pregnancy. Diabetes Metab Res Rev 2006, 22: 131–8.

    Article  PubMed  Google Scholar 

  29. Roca-Rodriguez MM, Lopez-Tinoco C, Fernandez-Deudero A, et al. Adipokines and metabolic syndrome risk factors in women with previous gestational diabetes mellitus. Diabetes Metab Res Rev 2012, 28: 542–8.

    Article  PubMed  Google Scholar 

  30. Butte NF, Hopkinson JM, Nicolson MA. Leptin in human reproduction: serum leptin levels in pregnant and lactating women. J Clin Endocrinol Metab 1997, 82: 585–9.

    Article  PubMed  Google Scholar 

  31. Telejko B, Kuzmicki M, Wawrusiewicz-Kurylonek N, et al. Plasma apelin levels and apelin/APJ mRNA expression in patients with gestational diabetes mellitus. Diabetes Res Clin Pract 2010, 87: 176–83.

    Article  PubMed  Google Scholar 

  32. Boucher J, Masri B, Daviaud D, et al. Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology 2005, 146: 1764–71.

    Article  PubMed  Google Scholar 

  33. Castan-Laurell I, Dray C, Attane C, Duparc T, Knauf C, Valet P. Apelin, diabetes, and obesity. Endocrine 2011, 40: 1–9.

    Article  PubMed  Google Scholar 

  34. Megia A, Vendrell J, Gutierrez C, et al. Insulin sensitivity and resistin levels in gestational diabetes mellitus and after parturition. Eur J Endocrinol 2008, 158: 173–8.

    Article  PubMed  Google Scholar 

  35. Haider DG, Handisurya A, Storka A, et al. Visfatin response to glucose is reduced in women with gestational diabetes mellitus. Diabetes Care 2007, 30: 1889–91.

    Article  PubMed  Google Scholar 

  36. Soheilykhah S, Mohammadi M, Mojibian M, et al. Maternal serum adiponectin concentration in gestational diabetes. Gynecol Endocrinol 2009, 25: 593–6.

    Article  PubMed  Google Scholar 

  37. Fasshauer M, Paschke R. Regulation of adipocytokines and insulin resistance. Diabetologia 2003, 46: 1594–603.

    Article  PubMed  Google Scholar 

  38. Tsai PJ, Yu CH, Hsu SP, et al. Maternal plasma adiponectin concentrations at 24 to 31 weeks of gestation: negative association with gestational diabetes mellitus. Nutrition 2005, 21: 1095–9.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinical Center of Endocrinology, Medical University Sofia, Sofia, Bulgaria

    M. Boyadzhieva, I. Atanasova & S. Zacharieva

  2. University Hospital of Obstetrics and Gynecology, Medical University Sofia, Sofia, Bulgaria

    S. Kedikova

Authors
  1. M. Boyadzhieva
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. I. Atanasova
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Zacharieva
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. Kedikova
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Boyadzhieva.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Boyadzhieva, M., Atanasova, I., Zacharieva, S. et al. Adipocytokines during pregnancy and postpartum in women with gestational diabetes and healthy controls. J Endocrinol Invest 36, 944–949 (2013). https://doi.org/10.3275/8968

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.3275/8968

Key-words

Search

Navigation